Loading data for AMGN — first visit, this takes a few seconds.
Amgen Inc. (AMGN)
NasdaqGS: AMGN
· Real-Time Price · USD
437.23
-6.89 (-1.55%)
At close: Sep 04, 2026, 8:00 PM
415.00
-5.08%
After-hours: 7:59 PM
The price, the headline numbers and the latest news, in one place.
Amgen Inc. (AMGN) Stock Price, Analysis & Data
No data available
| Bid | 437.47 |
| Market Cap | 236B |
| Revenue (ttm) | 38.1B |
| Net Income (ttm) | 8.74B |
| 0.43 | |
| 16.09 | |
| 27.17 | |
| 17.91 | |
| P/B (ttm) | 20.22 |
| P/S (ttm) | 6.21 |
| Earnings Date | Nov 3, 2026 |
| Ask | 430.6 |
| Volume | 1,656,089 |
| Avg. Volume (20D) | 2,657,507 |
| Open | 435.01 |
| Previous Close | 444.12 |
| Day's Range | 435.01 - 441.66 |
| 52-Week Range | 269.77 - 447.03 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $10.08 (2.31%) |
| Ex-Dividend Date | Aug 21, 2026 |
About AMGN
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events ...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jun 17, 1983
Employees 31,500
Stock Exchange NasdaqGS
Ticker Symbol AMGN
Website https://www.amgen.com
Financial Performance
In 2025, Amgen's revenue was 36.75B, an increase of 9.95% compared to the previous year's 33.42B. Earnings were 7.71B, an increase of 88.53%.
Financial StatementsEarnings Surprise
Amgen has released their quarterly earnings on Aug 4, 2026:
- Revenue of $10.05B misses estimates by $0, with 9.53% YoY growth.
- EPS of 6.29 exceeds estimates by 0.67, with 4.49% YoY growth.
Amgen Inc. is scheduled to release its earnings on Nov 3, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2